Tesamorelin 2mg


Tesamorelin by Nucleus Research

1x Vial of 2mg Lyophilized powder

In stock


Studied as a way to reduce excess deep belly fat, the synthetic human growth hormone releasing factor called tesamorelin (Egrifta) was approved by the FDA in November 2010 and has been available since January 2011. Results from a 52-week study of 816 people showed 18% less deep belly fat in those on tesamorelin than those taking placebo.


There are no reviews yet.

Be the first to review “Tesamorelin 2mg”